Citrulline Malate

The dosage of Citrulline Malate varies significantly depending on the clinical indication and the specific formulation used. It is essential to distinguish between the 1:1 and 2:1 ratios of citrulline to malate, as this affects the total amount of active amino acid delivered.

• For Functional Asthenia: The standard adult dose is typically 1 gram (one ampoule or tablet) taken three times daily. This provides a steady supply of metabolic intermediates throughout the day to combat fatigue. Treatment is usually limited to 4 weeks unless otherwise directed by a physician.
• For Exercise Performance and Recovery: Clinical trials often utilize higher doses ranging from 6 grams to 8 grams taken approximately 60 minutes before physical activity. Some protocols suggest a daily maintenance dose of 3 grams to support vascular health and ongoing recovery.
• For Metabolic Support: Dosage is highly individualized and must be managed by a metabolic specialist, often involving 100-200 mg/kg of body weight in divided doses.

Citrulline Malate is not routinely recommended for pediatric use unless specifically prescribed by a specialist for a diagnosed metabolic disorder.

• Children (ages 6-18): In some jurisdictions, a reduced dose of 1 gram twice daily may be used for fatigue, but this must be supervised by a pediatrician.
• Infants and Toddlers: Safety and efficacy have not been established in this population for general fatigue. Use is strictly limited to the management of rare urea cycle defects under intensive medical supervision.

Renal Impairment

Because the kidneys are the primary site for the conversion of citrulline to arginine, patients with moderate to severe renal impairment (CrCl < 30 mL/min) should use Citrulline Malate with caution. While no specific dose reduction is mandated by standard labeling, healthcare providers may monitor for signs of metabolic imbalance or nitrogen retention.

Hepatic Impairment

Citrulline Malate does not undergo significant hepatic metabolism; therefore, no specific dosage adjustments are generally required for patients with liver disease. However, since the liver is the primary site of the urea cycle, patients with end-stage liver disease or hepatic encephalopathy must be monitored closely, as the introduction of amino acids can theoretically impact ammonia levels.

Elderly Patients

No specific dosage adjustment is required for the elderly; however, providers should consider the higher prevalence of underlying cardiovascular or renal conditions in this population. A starting dose at the lower end of the spectrum (e.g., 1g twice daily) may be prudent.

• Administration: Oral solutions should be taken during meals to minimize potential gastrointestinal upset. Powdered forms should be thoroughly dissolved in at least 8 to 12 ounces of water or juice.
• Taste: Due to the malic acid component, Citrulline Malate has a distinctively sour or tart taste. Mixing with a non-acidic beverage can help mask this.
• Timing: For fatigue, space doses evenly throughout the day. For athletic performance, take the full dose 60 minutes before exercise.
• Storage: Store at room temperature (15°C to 30°C or 59°F to 86°F) away from moisture and direct sunlight. Keep ampoules or containers tightly closed.

If a dose is missed, it should be taken as soon as remembered. However, if it is nearly time for the next scheduled dose, skip the missed dose and resume the regular schedule. Do not double the dose to make up for a missed one, as this increases the risk of gastrointestinal side effects.

Acute toxicity from Citrulline Malate is extremely low. In the event of a significant overdose, the most likely symptoms are severe gastrointestinal distress, including nausea, abdominal cramping, and osmotic diarrhea. There is no specific antidote. Treatment involves supportive care and hydration. If an massive overdose occurs in a patient with compromised renal function, seek emergency medical attention to monitor for electrolyte imbalances.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop the medication without medical guidance, especially if being used for a diagnosed metabolic condition.

Citrulline Malate is generally well-tolerated, but the most frequently reported side effects are gastrointestinal in nature. These symptoms are often dose-dependent.

• Stomach Upset and Nausea: A feeling of queasiness or discomfort in the upper abdomen. This is most common when the supplement is taken on an empty stomach or in doses exceeding 8 grams.
• Abdominal Cramping: Sharp or dull pains in the mid-section, often occurring shortly after ingestion.
• Osmotic Diarrhea: Loose or watery stools caused by the high concentration of the compound drawing water into the intestines. This typically resolves once the dose is adjusted or the body becomes accustomed to the supplement.

• Heartburn or Acid Reflux: Due to the acidic nature of malic acid, some patients may experience a burning sensation in the chest or throat (pyrosis).
• Headache: Mild tension-type headaches may occur as the body adjusts to changes in nitric oxide levels and systemic blood flow.
• Bloating and Flatulence: Increased gas production or a feeling of fullness in the abdomen.

• Dizziness or Lightheadedness: This may be related to the vasodilatory effects of nitric oxide, which can cause a transient drop in blood pressure, particularly when moving from a sitting to a standing position (orthostatic hypotension).
• Paresthesia: A temporary tingling or "pins and needles" sensation in the extremities, though this is much more common with beta-alanine than with Citrulline Malate.
• Insomnia: Some patients report difficulty falling asleep if the dose is taken late in the evening, likely due to increased metabolic activity.

While Citrulline Malate is a naturally occurring metabolite, serious adverse reactions can occur, particularly in vulnerable populations.

> Warning: Stop taking Citrulline Malate and call your doctor immediately if you experience any of the following:

• Severe Allergic Reaction (Anaphylaxis): Symptoms include hives, swelling of the face, lips, or tongue, difficulty breathing, or a rapid, weak pulse. Although rare, hypersensitivity to any component of the formulation can be life-threatening.
• Significant Hypotension: Signs include extreme dizziness, fainting (syncope), or blurred vision. This is a risk if Citrulline Malate is combined with other blood-pressure-lowering medications.
• Severe Electrolyte Imbalance: Persistent vomiting or diarrhea that leads to extreme thirst, confusion, or muscle weakness.
• Chest Pain: Any new or worsening chest pain (angina) should be evaluated immediately, as changes in blood flow can affect cardiovascular dynamics.

Data on the continuous, multi-year use of high-dose Citrulline Malate is limited. However, potential long-term considerations include:

• Metabolic Adaptation: The body may adjust its endogenous production of citrulline or arginine in response to chronic supplementation, though clinical evidence of a "withdrawal" or "rebound" effect is lacking.
• Renal Stress: While not nephrotoxic in healthy individuals, the long-term processing of high nitrogen loads (from amino acids) could theoretically impact patients with pre-existing borderline kidney function.
• Dental Erosion: Because oral solutions and powders are acidic (due to malic acid), frequent use without proper oral hygiene could potentially weaken tooth enamel over several years.

No FDA black box warnings have been issued for Citrulline Malate as of 2026. It is generally recognized as safe (GRAS) when used within recommended dosage parameters. However, patients must adhere to the warnings regarding drug interactions and pre-existing conditions.

Report any unusual symptoms or persistent side effects to your healthcare provider to ensure continued safety and efficacy of the treatment.

Citrulline Malate should only be used as part of a comprehensive health or performance plan under the guidance of a healthcare professional. It is not a substitute for a balanced diet, adequate sleep, or medical treatment for underlying diseases. Patients should be aware that while it is a "natural" compound, it exerts significant physiological effects on the cardiovascular and metabolic systems.

There are currently no FDA black box warnings for Citrulline Malate. It has a high safety profile in the general population when used at standard doses (up to 8g/day).

• Allergic Reactions / Anaphylaxis Risk: Individuals with a known hypersensitivity to L-citrulline, malic acid, or any inactive ingredients (such as flavorings or preservatives in oral solutions) should avoid this product. Signs of an allergic reaction require immediate medical intervention.
• Cardiovascular Risk (Hypotension): Because Citrulline Malate increases nitric oxide production, it can lower systemic blood pressure. This effect may be pronounced in patients already taking antihypertensive medications or those with naturally low blood pressure. Monitoring of blood pressure is recommended when starting therapy.
• Renal Disease: Patients with chronic kidney disease (CKD) must use Citrulline Malate with extreme caution. The conversion of citrulline to arginine occurs in the kidneys, and an inability to process nitrogenous waste could lead to a buildup of metabolites.
• Surgery: Due to its effects on blood pressure and vasodilation, it is generally recommended to discontinue Citrulline Malate at least 2 weeks prior to elective surgical procedures. This helps avoid potential complications with blood pressure management during anesthesia.
• Urea Cycle Disorders: While used in the management of these conditions, it must only be done under the strict supervision of a metabolic geneticist. Improper use in these patients can be dangerous.

For patients using Citrulline Malate long-term or at high doses, healthcare providers may require the following monitoring:

• Blood Pressure: Regular checks to ensure the patient is not experiencing asymptomatic hypotension.
• Renal Function Tests: Periodic measurement of Serum Creatinine and Blood Urea Nitrogen (BUN), especially in older adults or those with pre-existing kidney issues.
• Ammonia Levels: In specific clinical settings (e.g., urea cycle management), plasma ammonia monitoring is essential.

Citrulline Malate generally does not impair the ability to drive or operate heavy machinery. However, if a patient experiences dizziness or lightheadedness due to blood pressure changes, they should avoid these activities until the symptoms resolve and they have consulted their doctor.

Alcohol can exacerbate the vasodilatory effects of Citrulline Malate, potentially leading to increased dizziness or a significant drop in blood pressure. Additionally, alcohol can impair the metabolic recovery processes that Citrulline Malate is intended to support. It is advisable to limit alcohol consumption while taking this compound.

There is no evidence that Citrulline Malate causes physical dependence or withdrawal symptoms. It can generally be discontinued abruptly without the need for a tapering schedule. However, patients using it for functional asthenia may notice a return of fatigue symptoms upon discontinuation.

> Important: Discuss all your medical conditions, especially heart or kidney problems, with your healthcare provider before starting Citrulline Malate.

• Nitrates (e.g., Nitroglycerin, Isosorbide Mononitrate): Citrulline Malate must NEVER be used in combination with prescription nitrates used for chest pain (angina). Both substances increase nitric oxide levels. Using them together can cause a severe, life-threatening drop in blood pressure (profound hypotension) that may lead to fainting, stroke, or heart attack.
• PDE5 Inhibitors (e.g., Sildenafil, Tadalafil, Vardenafil): Combining Citrulline Malate with medications for erectile dysfunction can result in additive vasodilatory effects. This combination significantly increases the risk of symptomatic hypotension.

• Antihypertensive Medications: This includes ACE inhibitors, Beta-blockers, Calcium Channel Blockers, and Diuretics. Citrulline Malate may enhance the blood-pressure-lowering effects of these drugs. Patients may require dosage adjustments of their blood pressure medications to avoid hypotension.
• Organic Nitrites ("Poppers"): Recreational use of amyl nitrite or similar substances in combination with Citrulline Malate is extremely dangerous and can lead to fatal cardiovascular collapse.

• Antidiabetic Drugs: Some evidence suggests that L-arginine (the metabolite of citrulline) may influence insulin sensitivity and glucose metabolism. Patients on insulin or oral hypoglycemics should monitor their blood sugar levels closely when starting Citrulline Malate.
• Anticoagulants / Antiplatelets: While not a direct interaction, the improved blood flow and potential minor effects on platelet aggregation associated with nitric oxide may theoretically increase bruising risk in patients on Warfarin or Clopidogrel. Monitor for unusual bleeding.

• High-Protein Meals: While not a negative interaction, a very high protein intake provides competing amino acids that may slightly alter the absorption kinetics of L-citrulline, though this is rarely clinically significant.
• Watermelon: Watermelon is a natural source of L-citrulline. Consuming large amounts while supplementing with Citrulline Malate may lead to an unexpectedly high total dose, increasing the risk of GI side effects.
• Caffeine: Many athletic supplements combine Citrulline Malate with caffeine. While they work via different pathways, the combination can increase heart rate and blood pressure, potentially masking the vasodilatory benefit of the citrulline.

• L-Arginine: Taking both supplements simultaneously is generally redundant, as citrulline is more effective at raising arginine levels than arginine itself. It may increase the risk of GI upset.
• Nitrate-Rich Supplements (e.g., Beetroot Juice): These also increase nitric oxide via a different pathway (nitrate-nitrite-NO). While often used together by athletes, the combination can lead to significant vasodilation and should be approached with caution by those with low blood pressure.
• Pycnogenol / Pine Bark Extract: These supplements also stimulate nitric oxide synthase and may have additive effects with Citrulline Malate.

• Plasma Amino Acid Profiles: Supplementation will naturally result in significantly elevated levels of citrulline and arginine, which may complicate the diagnosis of certain metabolic disorders if the lab is unaware of the supplement use.
• Urea and BUN: Minor elevations in Blood Urea Nitrogen may occur as the body processes the additional nitrogen from the amino acid.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, as the cardiovascular effects of Citrulline Malate are significant.

Citrulline Malate must NEVER be used in the following circumstances:

• Known Hypersensitivity: Any previous allergic reaction to L-citrulline or malic acid is an absolute contraindication. The risk of anaphylaxis outweighs any potential benefit.
• Concomitant Nitrate Therapy: Patients currently using any form of prescription nitroglycerin or other nitrates for heart disease must not use Citrulline Malate due to the risk of fatal hypotension.
• Severe Renal Failure: In patients with end-stage renal disease (ESRD), the inability to excrete nitrogenous waste and the impaired conversion of citrulline make the use of this compound potentially toxic.
• Children under 6 Years: Unless specifically prescribed for a rare urea cycle disorder, Citrulline Malate is contraindicated in young children due to a lack of safety data and the risk of metabolic imbalance.

Conditions requiring a careful risk-benefit analysis and close medical supervision include:

• Pre-existing Hypotension: Patients with baseline blood pressure lower than 90/60 mmHg may experience symptomatic fainting or dizziness.
• Pregnancy and Lactation: Due to the absence of robust clinical trials in these populations, use is generally discouraged unless the medical need clearly outweighs the unknown risks.
• Active Peptic Ulcer Disease: The acidic nature of malic acid may irritate the gastric mucosa and exacerbate symptoms of ulcers or severe GERD.
• Recent Myocardial Infarction: Patients who have recently suffered a heart attack should avoid starting new supplements that alter vascular dynamics until cleared by a cardiologist.

There are no well-documented cases of cross-sensitivity between Citrulline Malate and other common drug classes. However, individuals who are sensitive to other organic acids (like citric acid) or amino acid supplements should monitor themselves closely for similar reactions.

> Important: Your healthcare provider will evaluate your complete medical history, including cardiovascular and renal health, before determining if Citrulline Malate is safe for you.

Citrulline Malate is currently classified as Category C (or equivalent in most jurisdictions), meaning that animal reproduction studies have not been conducted and there are no adequate and well-controlled studies in humans.

• Trimester-Specific Risks: There is no data suggesting specific teratogenic effects; however, the alteration of nitric oxide levels could theoretically affect uteroplacental blood flow.
• Clinical Recommendation: Pregnant women should avoid Citrulline Malate unless it is prescribed by a physician for a specific medical condition (e.g., managing certain pregnancy-related vascular issues under research protocols). General use for fatigue or exercise during pregnancy is not recommended.

It is unknown whether supplemental Citrulline Malate is excreted in human milk. While L-citrulline is a natural component of breast milk, the high concentrations achieved through supplementation have not been studied for safety in nursing infants.

• Risk-Benefit: Because the effects on a developing infant's metabolism and blood pressure are unknown, breastfeeding women should consult their healthcare provider. In most cases, discontinuation of the supplement is advised while nursing.

Citrulline Malate is not approved for general use in children to treat fatigue. Its use in the pediatric population is strictly limited to:

• Urea Cycle Disorders: Specialized use under the direction of a metabolic team.
• Post-Surgical Recovery: Some pediatric cardiac centers use citrulline to manage pulmonary hypertension post-surgery, but this is an inpatient, high-acuity application.
• Growth Effects: There is no evidence that Citrulline Malate affects growth or development in children, but long-term data is lacking.

Elderly patients may benefit from Citrulline Malate for functional asthenia, but several precautions apply:

• Fall Risk: The potential for orthostatic hypotension (dizziness upon standing) significantly increases the risk of falls and fractures in the elderly.
• Renal Clearance: Age-related decline in GFR (Glomerular Filtration Rate) means that the nitrogenous load from amino acids must be monitored.
• Polypharmacy: Older adults are more likely to be on antihypertensive or nitrate therapies, making the risk of drug interactions much higher.

• Mild to Moderate (GFR 30-60 mL/min): Use with caution. Monitor BUN and Creatinine levels. No specific dose adjustment is usually required, but the lowest effective dose should be used.
• Severe (GFR < 30 mL/min): Use is generally discouraged. The risk of metabolic acidosis or nitrogen retention is increased.
• Dialysis: Citrulline is likely dialyzable, but its use in dialysis patients has not been standardized and should be avoided unless managed by a nephrologist.

In patients with mild to moderate hepatic impairment (Child-Pugh Class A or B), Citrulline Malate is generally considered safe as it does not rely on hepatic enzymes for its primary metabolism. However, in Class C (severe) impairment, the liver's inability to process the urea cycle could lead to complications. Close monitoring of ammonia levels is required in these patients.

> Important: Special populations require individualized medical assessment to ensure that the metabolic benefits of Citrulline Malate do not interfere with other health conditions.

Citrulline Malate exerts its effects through three primary pathways:

1. 1Nitric Oxide Synthesis: L-citrulline is converted to L-arginine in the kidneys by argininosuccinate synthetase and argininosuccinate lyase. This increases the systemic pool of arginine available for Nitric Oxide Synthase (NOS) to produce Nitric Oxide (NO). NO relaxes vascular smooth muscle, leading to vasodilation.
2. 2Ammonia Detoxification: As an intermediate in the urea cycle, citrulline facilitates the removal of ammonia. Ammonia inhibits the conversion of pyruvate to acetyl-CoA, which stalls the Krebs cycle. By lowering ammonia, Citrulline Malate prevents this metabolic "bottleneck."
3. 3ATP Production: The malate component is a dicarboxylic acid that enters the mitochondria. It helps skip certain steps in the Krebs cycle that may be compromised during hypoxia or intense exercise, allowing for more efficient ATP (energy) and phosphocreatine resynthesis.

• Dose-Response: There is a clear dose-response relationship between Citrulline Malate intake and plasma arginine levels. Doses below 3g have minimal impact on exercise performance, while 6-8g doses show significant effects on muscle fatigue markers.
• Onset and Duration: Metabolic changes (increased arginine) begin within 30 minutes. Peak physiological effects on vasodilation typically occur 60-90 minutes post-ingestion. The ergogenic effects generally last for 3 to 5 hours.
• Tolerance: There is no evidence of pharmacological tolerance; the body does not appear to downregulate its response to Citrulline Malate with repeated use.

| Parameter | Value |

|---|---|

| Bioavailability | High (>80%) |

| Protein Binding | Negligible |

| Half-life | 1.1 - 1.5 hours (Plasma Citrulline) |

| Tmax | 0.75 - 1.5 hours |

| Metabolism | Renal conversion to Arginine; Malate via TCA cycle |

| Excretion | Renal (minimal unchanged), primarily as Urea |

• Molecular Formula: C6H13N3O3 (Citrulline) + C4H6O5 (Malic Acid)
• Molecular Weight: ~309.27 g/mol (as a complex)
• Solubility: Highly soluble in water, resulting in an acidic solution.
• Structure: L-citrulline is an alpha-amino acid with a carbamoyl group. Malic acid is a dicarboxylic acid. They are typically combined in a 1:1 or 2:1 molar ratio.

Citrulline Malate is classified as an Amino Acid / Metabolic Intermediate. Within the EPC (Established Pharmacologic Class) framework, it is often grouped with Nicotinic Acid [EPC] or other Vasoactive Agents due to its role in endothelial function and metabolic efficiency.